The interesting phenomenon of dysthymia disorder
K Y Mak 麥基恩
HK Pract 2003;25:224-230
Summary
In the past, the concept of dysthymia has been broadly used to include persons with
depressive personality and to those in various stages of depression. In recent years,
it has been narrowed down to mean those with a characteristic mild, chronic depression,
as part of an affective disorder. As prompt diagnosis and management may abort its
chronic morbidity, recognition of the disorder in the primary care setting is important.
Antidepressants especially the newer types are useful though maintenance therapy
may be necessary, and various psychological therapies, especially interpersonal
psychotherapy, may be adjunctive to improve the psychosocial functioning of the
patients.
摘要
從前,情緒失調這個概念被廣泛地用來包括抑鬱性格以至不同程度的抑鬱症患者。近年, 此概念被限制為表示輕度慢性的抑鬱症,是情緒病的一種。因為盡早診治可以中止其慢性病程,
所以基層醫生識別此病非常重要。維持治療方面,可能需要採用新的抗抑鬱藥物。各種心理治療, 尤其是人際關係的心理治療,可以輔助病人改善其心理社交功能。
Introduction
The term "dysthymia" has its origin in Greek meaning "ill-humoured", and refers
to melancholy which was a depressive personality spoken of by Hippocrates. This
term was used clinically by Kahbaum in 1863 as a chronic form of melancholia, while
"cyclothymia" was used for a fluctuating mood disorder.1 Kreapelin likewise
equated dysthymia with a "depressive temperament" (a form of neurotic "character")2
with affective episodes arising from unstable temperamental disturbances, and lacking
the psychotic symptoms of hospital cases of manic-depression.
In the DSM-II classification of the American Psychiatric Association, chronic depression
was initially called "depressive neurosis" under the section of personality disorders
and neuroses. Dysthymic disorder appeared in the DSM-III as a chronic depression
lasting more than two years, but not meeting the full severity or duration of a
major depressive disorder.
Clinical diagnosis
As chronic depression is increasingly being noted by primary care physicians rather
than by psychiatrists,3 the recognition of "dysthymic disorder" or "dysthymia"
is important. Though less severe than major depressive disorder, this psychiatric
disorder can cause quite a lot of functional impairment to the patients due to its
protracted course.4
According to the DSM-IV, dysthymic disorder is defined as "depressed mood" for most
of the day, for more days than not, as indicated either by subjective account or
observation by others, for at least two years (one year for children or adolescents).
While depressed, the patient has two or more of the following symptoms:
- poor appetite or overeating;
- insomnia or hypersomnia;
- low energy or fatigue;
- low self-esteem;
- poor concentration or difficulty making decisions; and
- feelings of hopelessness.
Dysthmia is divided into an early onset and a late onset type (cut-off age at 21
years). Akiskal further divided it into a secondary "character spectrum disorder"
and a primary "subaffective dysthymia".5 For the former, there is often
a personal or family history of substance abuse superimposed on an unstable personality.
For the subaffective dysthymia, the personality trait is often of the depressive
type, and there is more likely a family history of mood disorder. When the mood
brightens in response to positive events (be it actual or potential) and when there
is either increase in weight, appetite or sleep, the disorder may be called "atypical
dysthymic disorder".
For both typical and atypical conditions, there is clinically significant distress
or impairment in functioning, and the disorder is not caused by any other psychiatric
disorder (including major depressive disorder) or a general medical condition (including
the effects of a drug or medication). For children and adolescents, the mood can
be irritable. Within the two-year period, the person has never been without the
above symptoms for more than two months at a time, nor has there been any major
depressive episode. This means that major depressive disorder can be present prior
to or after the two year period. Furthermore, there has never been any hypomanic
episode, and the criteria have never been met for cyclothymic disorder that contains
numerous periods of elated mood.
In the ICD-10 of the W.H.O., there is no strict operational definition for dysthymia.
It states that "dysthymia has much in common with the concepts of long-standing
depressive neurosis and neurotic depression", and the depressive episodes must not
be severe enough to meet the diagnostic criteria for a recurrent depressive disorder.
Differential diagnosis
1. Chronic major depressive disorder
Major depressive disorder sometimes runs a chronic continuous course and can be
labeled as chronic major depressive disorder. Its main difference from a dysthymic
disorder is the lesser symptoms in the latter, which can sometimes be called "subsyndromal
depression" or "minor depression". Dysthymic disorder also differs by having an
insidious onset, but such distinction is not of any clinical difference. In the
DSM-IV classification the stress is on the cognitive symptoms of pessimism and low
self- esteem rather than the neuro-vegetative symptoms of a major depressive disorder.
There is indeed a close relation between dysthymic disorder and major depressive
disorder, and they often breed in the same family,6 and the former can
turn into the latter when followed prospectively. However, partially responsive
or refractory patients should not be diagnosed as "dysthymic disorder".
2. Double depression
This is a major depressive disorder superimposed on a dysthymic disorder. Pure dysthymia
is relatively uncommon in clinical practice. Patients with dysthymia often develop
major depressive episodes with symptom exacerbation (with additional symptoms lasting
for 2 weeks or more). The DSM-IV field trial7 found that 79% of the subjects
also had a life-time history of major depression. However, this term "double depression"
may erroneously indicate that the patient is having two distinct mood disorders,
but that is not real.
3. Depressive personality disorder
In the past, dysthymia has been regarded as a character problem. The DSM-II considered
depressive personality disorder as a distinct entity that can exist concurrently.
In the DSM-IV, this personality disorder is only included in the appendix. Klein
& Miller8 provided evidence that although depressive personality
and dysthymia are overlapping constructs, the former is not completely subsumed
by mood disorders categories. However, some would consider the two conditions as
"trait" and "state" differences only, and that depressive personality disorder should
only be considered when the patient has not responded to antidepressive therapies.
4. Adjustment disorder
When a depression occurs amidst a specific aversive life-event e.g. bereavement,
and it continues as long as the event is present, it is best considered an adjustment
disorder. But if such condition becomes chronic, the diagnosis can be replaced by
"dysthymic disorder" as it reflects a more basic affective dysregulation.9
If the patient subsequently develops an anxiety disorder or a major depressive disorder,
there should be reclassification again.
5. Mixed anxiety and depression
This is a heterogenous group10 not well differentiated, and is not included
in the DSM-IV. In the ICD-10, it is a term to be used when "symptoms of both anxiety
and depression are present but neither, considered separately, is sufficiently severe
to justify a diagnosis". It can be considered part of a major depressive disorder
with autonomic hyperactivity, including panic attacks.
6. Neurasthenia
Beard in 188111 coined the term to mean a chronic stage of anxiety-depression,
characterised by chronic irritability and mental fatigue and exhaustion. It has
been used quite popularly in China to denote a variety of non-psychotic disorders12
especially anxiety and mood disorders. But in Western psychiatric classification,
it is associated with the chronic fatigue syndrome,13 and should be distinguishable
from dysthymic disorder.
Prevalence
Dysthymic disorder usually begins early in adult life. If it occurs later in life,
it is often the aftermath of a depressive episode, and is associated with some obvious
stress such as bereavement. Kessler et al1 in the National Comorbidity
Study suggested that up to 3% of the American adults in their life-time have dysthymic
disorder, including 4% of women; while the point prevalence was 1.6%. The prevalence
rate at psychiatric clinics can be as high as 36%.14 According to the
Epidemiological Catchment Area (ECA) study in the US,15 those 18 to 64
years of age were at greater risk than those over 65. Diagnosis was greatest among
women aged between 45 and 64 years old. Those between the 18 and 44 age range who
reported low income were also at risk. Race, education and employment status did
not affect likelihood of having the disorder. However, the rate is much lower in
European countries, perhaps due to the existence of the "recurrent brief depression"
entity in the ICD-10. For example, Angst reported the life-time prevalence in Zurich
as only 0.9%.16
Comorbidity
Dysthymic patients are likely to seek medical and mental health care, but are often
under-recognised. Spitzer et al17 found that dysthymic subjects
frequently suffer from another psychiatric disorder: mainly other types of mood
disorders, anxiety disorders and avoidant personality disorders. There is also an
increased risk of substance abuse including alcoholism. On the other hand, Akiskal
stated that many borderline personality disordered patients also suffered from dysthymia
and cyclothymia, with transient shifts into affective episodes.18 Besides
medical morbidity, the patients also suffer chronic work and social disabilities,
with a high utilisation of psychiatric and general health care services.19
They have a low self-esteem, despite their loyalty to work and hard labour. They
frequently feel miserable in life, and have difficulty in enjoying leisure time.
They regard inter-personal relationships as hopeless, their "badness" will eventually
lead to rejection by others.
Treatment
The development of empathy or rapport is not easy as the patients tend to irritate
and alienate their doctors. In the past, dysthymia was regarded as a chronic personality
disorder and had been managed mainly by psychotherapy especially the analytical
type. But it is now considered a mood disorder and the most important point is early
recognition, even in the primary care setting.
- Pharmacotherapy
Dysthymia is notable for its low placebo response rate, but Akiskal20
first demonstrated successful treatment with antidepressants, especially for his
primary subaffective dysthymic patients. Kocsis et al21 also
found that the tricyclics such as imipramine are more effective than placebo. The
clinical improvement can affect the social and vocational functioning as well. Other
types of antidepressants e.g. the MAOIs22 and its newer reversible form
such as Moclobemide,23 the second generation antidepressants SSRIs,24,25
and the third generation antidepressants such as Venlafaxine26 and Mirtazapine,27
are all effective. The therapeutic dosage of these antidepressants is similar to
that for major depression, but dysthymic patients oftentolerate the tricyclic antidepressants
less well than genuine depressive patients.23 In contrast to major depressive
episodes, long-term maintenance treatment is often necessary to prevent relapse
and recurrence, and cessation of medication may carry the risk of relapse. For those
with a family history of bipolar disorder, and those with "soft bipolarity", lithium
or valproate therapy or augmentation can be used.
- Psychotherapy
The use of time-limited manualised therapies as for major depression seems helpful.
The use of psychoanalysis is not convincing, but cognitive-behavioural therapies
showed a response rate of around 40%.28 Specific anti-dysthymic psychotherapy
is indicated when medication response is not satisfactory. The use of "interpersonal
psycho-therapy" (ITP) that focuses on social adjustment rather than past or intrapsychic
experience is particularly useful.29 The technique is described in detail
by Markowitz.14
Combining medication and psychotherapy is often useful. Psycho-educational approaches
for both patient and spouse are needed to combat the demoralising nature of the
disorder, and may address the personality difficulties. Sometimes marital and family
therapies are beneficial, while social skills training and group support are also
realistic.30
Prognosis
Historically, dysthymics are difficult to treat, as they are "self-defeating" patients
especially in psychotherapy. The disorder usually lasts for at least several years
and sometimes for life, and the patients view themselves as long-term sufferers
with continuous symptoms and psychosocial morbidity.31 Without a superimposed
major depression, hospitalisation is not necessary, and most patients function adequately
at work and socially, albeit with difficulty. Despite the recent advances in the
treatment of mood disorders especially depression, the overall outcome for dysthymia
is still relatively poor with high relapse rate. However, it sometimes responds
quite well to pharmacotherapy (about 60%) and/or focused psychotherapy. A few patients
develop hypomanic spells with antidepressants, and as happens in major depression
some patients do end up in suicide.32
Conclusion
"Dysthymic disorder" is a modern term that cuts across disorders of anxiety, mood
and even personality. The recent concept points to a subsyndromal but persistent
form of an affective disorder, but without psychotic features. Nevertheless, dysthymia
can cause significant morbidity. However, it can be quite responsive to psychological
and pharmacological treatments. The newer types of antidepressants are relatively
safe, and can be of particular use even in the primary care setting.
Key messages
- Primary care doctors often encounter patients with a mixture of fluctuating anxiety
and depressive symptoms that persist for a long time.
- These patients are often diagnosed as suffering from anxiety depression or neurotic
depression, and even "personality disorder".
- As a result, they are treated mainly with anxiolytics (especially benzodiazepines)
with or without a subtherapeutic dosage of anti-depressant.
- Nowadays, these patients can be re-diagnosed as "dysthymics" and they belong more
to the mood disorder category; they could also be called chronic "minor depression"
or "subsyndromal depression".
- Dysthymia has a more insidious onset, with less neuro-vegetative symptoms than a
major depressive disorder, and runs a chronic course with significant morbidities.
- The mainstay of treatment is an antidepressant rather than an anxiolytic, and this
should be given in an adequate dosage for an adequate time, sometimes for a long
duration. It can be supplemented with a limited period of benzodiazepine when coexisting
anxiety symptoms are marked.
- Rapport is important to engage the patient for long-term care, and skills in cognitive-behavioural
or interpersonal psychotherapies can, in addition, improve the psychosocial functioning.
K Y Mak, MBBS, DPM, MD, FRCPsych
Honorary Professor,
Department of Psychiatry, The University of Hong Kong.
Correspondence to : Dr K Y Mak, Department of Psychiatry, The University
of Hong Kong, Queen Mary Hospital, Hong Kong.
References
- Freeman HL. Historical and nosological aspects of dysthymia. Acta Psychiatrica Scandinavica
1994;89(suppl 383):7-11.
- Kraepelin E. Manic-depressive Insanity and Paranoia. In: Barclay RM., Trans., Robertson
GM, (eds.) Edinburgh: E.S. Livingstone 1921.
- Akiskal HS, Cassano GB. Dysthymia and the Spectrum of Chronic Depressions. New York:
The Guilford Press 1997.
- Keller MB. Course, outcome and impact on the community. Acta Psychiatrica Scandinavica
1994;89(suppl 383):24-34.
- Akiskal HS. Towards a definition of dysthymia: boundaries with personality and mood
disorders. In: Burton SW, Akiskal HS (eds.) Dysthymic Disorder 1990;pp.1-12. London:
Gaskell.
- Maier W, Lichtermann D, Minges J, et al. Personality traits in subjects at risk
for unipolar major depression: a family study perspective. J Affect Disord 1992;24:153-163.
- Keller MB, Klein DN, Hirschfeld RMA, et al. Results of the DSM-IV mood disorders
field trial. Am J Psychiatry 1995;152:843-849.
- Klein DA, Miller GA. Depressive personality: realtionship to dysthymia and major
depression. In: Akiskal HS, Cassano GB (eds.) Dysthymia and the Spectrum of Chronic
Depressions. New York: The Guilford Press 1997;87-95.
- Rosenthal TL, Akiskal HS, Scott-Strauss A, et al. Familial and developmental factors
in characterologic depressions. J Affect Disord 1981;3:183-192.
- Akiskal HS. Toward a clinical understanding of the relationship of anxiety and depressive
disorders. In: Maser J, Cloninger R (eds.) Comorbidity in Anxiety and Mood Disorders.
Washington, D.C. American Psychiatric Press 1990;597-607.
- Beard GM. A Practical Treatise on Nervous Exhaustion (Neurasthenia): Its Nature,
Sequences, and Treatment. New York: W. Wood 1881.
- Kleinman A. Social Origins of Distress and Disease: Depression, Neurasthenia, and
Pain in Modern China. New Haven: Yale University Press 1986.
- Wessely S. Old wine in new bottles: neurasthenia and Wessely S. Old wine in new
bottles: neurasthenia and "ME"Psychol Med 1990;20:35-53.
- Markowitz JC, Moran ME, Korcis JH, et al. Prevalence and comorbidity of dysthymic
disorder among psychiatric outpatients. J Affect Disord 1992;24:63-71.
- Weissman MM, Leaf PJ, Bruce ML, et al . The epidemiology of dysthymia in five communities:
rates, risks, comorbidity, and treatment. Am J Psychiatry 1988;145:815-819.
- Angst A. How recurrent and predictable is depressive illness? In: Montgomery SA,
Rouillon F (eds.) Long-term Treatment of Depression. Chichester: Wiley 1992;1-14.
- Sptizer RL, Williams JBW, Gibbon M. Structural Clinical Interview for DSM-III-R
- Personality Disorders (SCID-II, 10/15/86). New York, Biometrics Research Department,
New York State Psychiatric Institute 1986.
- Akiskal HS. Subaffective disorders: dysthymic cyclothymic and bipolar II disorders
in the "borderline" realm. Psychiatr Clin North Am 1981;4:25-46.
- Klermaan GL, Weissman MM. The course, morbidity and costs of depression. Arch Gen
Psychiatry 1992;49:831-834.
- Akiskal HS. Dysthymic disorder: psychopathology of proposed chronic depressive subtypes.
Am J Psychiatry 1983;140:11-20.
- Korcis JH, Klein DN, Dysthymic disorder. Psychiatric Annals 1993;23:617-624.
- Vallejo J, Casto C, Catalan R, et al. Double-blind study of imipramine versusu phenelzine
in melancholias and dysthymic disorders. Br J Psychiatry 1987;151:639-642.
- Stabl MK, Biziere K, Schmid-Burgk W, et al. Review of comparative clinical trials.
Moclobemide vs. TCAs and vs. placebo in depressive states. J Neural Transmitters
1989;28(suppl):77-89.
- Thase ME, Fava M, Halbreich U, et al. A placebo-controlled, randomised clinical
trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen
Psychiatry 1996;53:777-784.
- Hellerstein DJ, Yanowitch P, Rosenthal J, et al. A randomised double-blind study
of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 1993;150:1169-1175.
- Dunner DL, Schmaling KB, Henderickson HE, et al. Venlafaxine in dysthymic disorder.
J Clin Psychiatry 1997;58:528-531.
- Dunner DL, Hendrickson HE, Carolyn Bea BS, et al. Dysthymic disorder: treatment
with Mirtazapine. Depress Anxiety 1999;10:68-72.
- Markowitz JC. Interpersonal Psychotherapy for Dysthymic Disorder. Washinton: American
Psychiatric Press, Inc 1998.
- Akiskal HS. Towards a definition of dysthymia: boundaries with personality and mood
disorders. In: Burton SW, Akiskal HS (eds.) Dysthymic Disorder. London: Gaskell
1990.
- Paykel ES. Psychological therapies. Acta Psychiatr Scand 1994;89(suppl 383):35-41.
- Thase ME, Fava M., Halbreich U, et al. A placebo-controlled trial comparing sertraline
and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996;53:777-784.
- Montgomery SA. Suicide in chronic and recurrent depressions. In: Akiskal HS, Cassano
GB (eds.) Dysthymia and the Spectrum of Chronic Depressions. New York: The Guilford
Press 1997;191-197.
|